IndraLab

Statements


2 | 3

reach
"Resveratrol (100muM) treatment reduced caspase-1 immunofluorescence intensity compared with ox-LDL-treated platelets."

No evidence text available

reach
"In a recent study [XREF_BIBR], it was found that resveratrol treatment successfully suppressed the maturation of both IL-1beta and caspase-1 in response to Pam3CSK4; a TLR1/2 agonist, plus various inducers (like nigericin, ATP, MSU, and silica) of the NLRP3-inflammasome."

reach
"Resveratrol pretreatment also inhibited the activation of NLRP3 and caspase-1, and reduced the production of inflammatory cytokines and ROS."

No evidence text available